Pitfalls in bone marrow pathology: Avoiding errors in bone marrow trephine biopsy diagnosis

Journal of Clinical Pathology

Volumn 64, Issue 5, 2011, Pages 380-386

  Wilkins, Bridget S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LABORATORY DIAGNOSIS; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SAMPLING; STROMA;

BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; CYTODIAGNOSIS; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; MEDICAL ERRORS;

EID: 79955095940     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.080838     Document Type: Review

References (18)

1. Bishop PW, McNally K, Harris M. Audit of bone marrow trephines. J Clin Pathol 1992;45:1105-8. (Pubitemid 23002014)
2. Lawson S, Aston S, Baker L, et al. Trained nurses can obtain satisfactory bone marrow aspirates and trephine biopsies. J Clin Pathol 1999;52:154-6. (Pubitemid 29062355)
3. Charles KS, Winfield DA, Angel C, et al. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma - a single centre study. Clin Lab Haematol 2004;26:403-6. (Pubitemid 39664882)
4. Bain BJ. Bone marrow biopsy morbidity: review of 2003. J Clin Pathol 2005;58:406-8.
5. Bain BJ. Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 2004;26:315-18.
6. Wilkins BS. Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis. J Clin Pathol 2011;64:380-6.
7. Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/ myeloproliferative diseases. Pathobiology 2007;74:97-114. (Pubitemid 46985282)
8. Dunphy CH, O'Malley DP, Perkins SL, et al. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias. Appl Immunohistochem Mol Morphol 2007;15:154-9. (Pubitemid 46828221)
9. Della Porta MG, Malcovati L, Boveri E, et al. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 2009;27:754-62.
10. Matsui WH, Brodsky RA, Smith BD, et al. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia 2006;20:458-62. (Pubitemid 43291744)
11. Reis SC, Traina F, Metze K, et al. Variation of bone marrow CD34+ cell subsets in myelodysplastic syndromes according to WHO types. Neoplasma 2009;56:435-40.
12. Matarraz S, López A, Barrena S, et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients. Cytometry B Clin Cytom 2010;78:154-68.
13. Mittelman M, Oster HS, Hoffman M, et al. The lower risk MDS patient at risk of rapid progression. Leuk Res 2010;34:1551-5.
14. Krause JR. Value of bone marrow biopsy in the diagnosis of amyloidosis. South Med J 1977;70:1072-4; 1079.
15. Horny HP, Sotlar K, Valent P. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review. Pathobiology 2010;77:169-80.
16. Lassmann S, Gerlach UV, Technau-Ihling K, et al. Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas. J Mol Diagn 2005;7:582-91. (Pubitemid 41601509)
17. Del Giudice I, Pileri SA, Rossi M, et al. Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Br J Haematol 2009;144:726-31.
18. Laurent C, de Paiva GR, Ysebaert L, et al. Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma. Am J Clin Pathol 2007;128:974-80.